Case Report
Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse
Table 1
Chemotherapy number of IT treatments total dose (mg).
| Methotrexate 10 mg | 2 | 20 mg | Methotrexate 12 mg | 45 | 540 mg | Methotrexate 15 mg | 6 | 90 mg | Cytarabine 20 mg | 2 | 40 mg | Cytarabine 30 mg | 4 | 120 mg | Cytarabine liposomal 50 mg | 1 | 50 mg | Cytarabine 70 mg | 14 | 980 mg | Cytarabine 75 mg | 2 | 150 mg | Cytarabine 100 mg | 4 | 400 mg | Thiotepa 10 mg | 3 | 30 mg | Hydrocortisone 15 mg | 9 | 135 mg | Rituximab 10 mg | 2 | 20 mg | Rituximab 25 mg | 5 | 125 mg |
|
|
Intrathecal chemotherapy received.
|